Skip to main content
Log in

Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Interferon-beta (IFN-β) is a cytokine with anti-viral, anti-proliferative, and immunomodulatory effects. In this study, we investigated the effects of IFN-β on the induction of autophagy and the relationships among autophagy, growth inhibition, and apoptosis induced by IFN-β in human glioma cells. We found that IFN-β induced autophagosome formation and conversion of microtubule associated protein 1 light chain 3 (LC3) protein, whereas it inhibited cell growth through caspase-dependent cell apoptosis. The Akt/mTOR signaling pathway was involved in autophagy induced by IFN-β. A dose- and time-dependent increase of p-ERK 1/2 expression was also observed in human glioma cells treated with IFN-β. Autophagy induced by IFN-β was suppressed when p-ERK1/2 was impaired by treatment with U0126. We also demonstrated that suppression of autophagy significantly enhanced growth inhibition and cell apoptosis induced by IFN-β, whereas inhibition of caspase-dependent cell apoptosis impaired autophagy induced by IFN-β. Collectively, these findings indicated that autophagy induced by IFN-β was associated with the Akt/mTOR and ERK 1/2 signaling pathways, and inhibition of autophagy could enhance the growth inhibitory effects of IFN-β and increase apoptosis in human glioma cells. Together, these findings support the possibility that autophagy inhibitors may improve IFN-β therapy for gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J (2005) IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65(17):7573–7579. doi:10.1158/0008-5472.CAN-05-0036

    PubMed  CAS  Google Scholar 

  2. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359(9311):1011–1018

    Article  PubMed  CAS  Google Scholar 

  3. Okazaki T, Kageji T, Kuwayama K, Kitazato KT, Mure H, Hara K, Morigaki R, Mizobuchi Y, Matsuzaki K, Nagahiro S (2012) Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma. Cancer Lett 323(2):199–207. doi:10.1016/j.canlet.2012.04.013

    Article  PubMed  CAS  Google Scholar 

  4. Auffinger B, Thaci B, Nigam P, Rincon E, Cheng Y, Lesniak MS (2012) New therapeutic approaches for malignant glioma: in search of the Rosetta stone. F1000 Med Rep 4:18. doi:10.3410/M4-18

    Article  PubMed  Google Scholar 

  5. Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J (2008) A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation. Cancer Chemother Pharmacol 61(4):653–659. doi:10.1007/s00280-007-0520-x

    Article  PubMed  CAS  Google Scholar 

  6. Saito R, Mizuno M, Hatano M, Kumabe T, Yoshimoto T, Yoshida J (2004) Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells. J Neurooncol 67(3):273–280

    Article  PubMed  Google Scholar 

  7. Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E (2009) Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Int J Oncol 35(1):139–148

    Article  PubMed  CAS  Google Scholar 

  8. Mahoney E, Lucas DM, Gupta SV, Wagner AJ, Herman SE, Smith LL, Yeh YY, Andritsos L, Jones JA, Flynn JM, Blum KA, Zhang X, Lehman A, Kong H, Gurcan M, Grever MR, Johnson AJ, Byrd JC (2012) ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Blood 120(6):1262–1273. doi:10.1182/blood-2011-12-400184

    Article  PubMed  CAS  Google Scholar 

  9. Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, Tang Z, Zhu Y, Chen S, Xu J, Yan M, Wang J, Liu Q (2012) Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 8(12):1798–810. doi:10.4161/auto.22110

    Google Scholar 

  10. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27–42. doi:10.1016/j.cell.2007.12.018

    Article  PubMed  CAS  Google Scholar 

  11. Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861–2873. doi:10.1101/gad.1599207

    Article  PubMed  CAS  Google Scholar 

  12. Corradetti MN, Guan KL (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25(48):6347–6360. doi:10.1038/sj.onc.1209885

    Article  PubMed  CAS  Google Scholar 

  13. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67–93. doi:10.1146/annurev-genet-102808-114910

    Article  PubMed  CAS  Google Scholar 

  14. Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306(5698):990–995. doi:10.1126/science.1099993

    Article  PubMed  CAS  Google Scholar 

  15. White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15(17):5308–5316. doi:10.1158/1078-0432.CCR-07-5023

    Article  PubMed  Google Scholar 

  16. Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9(12):1004–1010. doi:10.1038/nrm2529

    Article  PubMed  CAS  Google Scholar 

  17. Madeo F, Tavernarakis N, Kroemer G (2010) Can autophagy promote longevity? Nat Cell Biol 12(9):842–846. doi:10.1038/ncb0910-842

    Article  PubMed  CAS  Google Scholar 

  18. Marino G, Madeo F, Kroemer G (2011) Autophagy for tissue homeostasis and neuroprotection. Curr Opin Cell Biol 23(2):198–206. doi:10.1016/j.ceb.2010.10.001

    Article  PubMed  CAS  Google Scholar 

  19. Michallet AS, Mondiere P, Taillardet M, Leverrier Y, Genestier L, Defrance T (2011) Compromising the unfolded protein response induces autophagy-mediated cell death in multiple myeloma cells. PLoS One 6(10):e25820. doi:10.1371/journal.pone.0025820

    Article  PubMed  CAS  Google Scholar 

  20. Chan LL, Shen D, Wilkinson AR, Patton W, Lai N, Chan E, Kuksin D, Lin B, Qiu J (2012) A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8(9):1371–1382. doi:10.4161/auto.21028

    Article  PubMed  CAS  Google Scholar 

  21. Seglen PO, Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79(6):1889–1892

    Article  PubMed  CAS  Google Scholar 

  22. Pliyev BK, Menshikov M (2012) Differential effects of the autophagy inhibitors 3-methyladenine and chloroquine on spontaneous and TNF-alpha-induced neutrophil apoptosis. Apoptosis 17(10):1050–1065. doi:10.1007/s10495-012-0738-x

    Article  PubMed  CAS  Google Scholar 

  23. Kumar S (2007) Caspase function in programmed cell death. Cell Death Differ 14(1):32–43. doi:10.1038/sj.cdd.4402060

    Article  PubMed  CAS  Google Scholar 

  24. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70

    Article  PubMed  CAS  Google Scholar 

  25. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12(1):9–22. doi:10.1016/j.ccr.2007.05.008

    Article  PubMed  CAS  Google Scholar 

  26. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, Kondo S (2005) Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65(8):3336–3346. doi:10.1158/0008-5472.CAN-04-3640

    PubMed  CAS  Google Scholar 

  27. Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584(7):1287–1295. doi:10.1016/j.febslet.2010.01.017

    Article  PubMed  CAS  Google Scholar 

  28. Ogier-Denis E, Pattingre S, El Benna J, Codogno P (2000) Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 275(50):39090–39095. doi:10.1074/jbc.M006198200

    Article  PubMed  CAS  Google Scholar 

  29. Pattingre S, Bauvy C, Codogno P (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 278(19):16667–16674. doi:10.1074/jbc.M210998200

    Article  PubMed  CAS  Google Scholar 

  30. Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence. FEBS J 277(1):2–21. doi:10.1111/j.1742-4658.2009.07366.x

    Article  PubMed  CAS  Google Scholar 

  31. Park MY, Kim DR, Jung HW, Yoon HI, Lee JH, Lee CT (2010) Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta. Cancer Gene Ther 17(5):356–364. doi:10.1038/cgt.2009.78

    Article  PubMed  CAS  Google Scholar 

  32. Vitale G, Zappavigna S, Marra M, Dicitore A, Meschini S, Condello M, Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M (2012) The PPAR-gamma agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-beta treated pancreatic cancer cells. Biotechnol Adv 30(1):169–184. doi:10.1016/j.biotechadv.2011.08.001

    Article  PubMed  CAS  Google Scholar 

  33. Olson MV, Lee J, Zhang F, Wang A, Dong Z (2006) Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Cancer Gene Ther 13(7):676–685. doi:10.1038/sj.cgt.7700941

    Article  PubMed  CAS  Google Scholar 

  34. Paty DW, Li DK (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43(4):662–667

    Article  PubMed  CAS  Google Scholar 

  35. Ruotsalainen J, Martikainen M, Niittykoski M, Huhtala T, Aaltonen T, Heikkila J, Bell J, Vaha-Koskela M, Hinkkanen A (2012) Interferon-beta sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models. Mol Ther 20(8):1529–1539. doi:10.1038/mt.2012.53

    Article  PubMed  CAS  Google Scholar 

  36. Paillas S, Causse A, Marzi L, de Medina P, Poirot M, Denis V, Vezzio-Vie N, Espert L, Arzouk H, Coquelle A, Martineau P, Del Rio M, Pattingre S, Gongora C (2012) MAPK14/p38alpha confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy 8(7):1098–112. doi:10.4161/auto.20268

    Google Scholar 

  37. Kong D, Ma S, Liang B, Yi H, Zhao Y, Xin R, Cui L, Jia L, Liu X (2012) The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Biomed Pharmacother 66(4):271–278. doi:10.1016/j.biopha.2011.12.002

    Article  PubMed  CAS  Google Scholar 

  38. Sun J, Desai MM, Soong L, Ou JH (2011) IFN-alpha/beta and autophagy: tug-of-war between HCV and the host. Autophagy 7(11):1394–1396. doi:10.4161/auto.7.11.17514

    Article  PubMed  CAS  Google Scholar 

  39. Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J (2011) Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Gastroenterology 141(2):674–685. doi:10.1053/j.gastro.2011.04.060, 685 e671-676

    Article  PubMed  CAS  Google Scholar 

  40. Liang C (2010) Negative regulation of autophagy. Cell Death Differ 17(12):1807–1815. doi:10.1038/cdd.2010.115

    Article  PubMed  CAS  Google Scholar 

  41. Lomonaco SL, Finniss S, Xiang C, Lee HK, Jiang W, Lemke N, Rempel SA, Mikkelsen T, Brodie C (2011) Cilengitide induces autophagy-mediated cell death in glioma cells. Neuro Oncol 13(8):857–865. doi:10.1093/neuonc/nor073

    Article  PubMed  CAS  Google Scholar 

  42. Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5(9):726–734. doi:10.1038/nrc1692

    Article  PubMed  CAS  Google Scholar 

  43. Sivaprasad U, Basu A (2008) Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med 12(4):1265–1271. doi:10.1111/j.1582-4934.2008.00282.x

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Shanghai Science and Technology Funds (11431920104, 09XD1421800), National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China (2011ZX09102-001-27), and the National Key Basic Research Program of China (2013CB932502).

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dianwen Ju.

Additional information

Y.L. and H.Z. contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Zhu, H., Zeng, X. et al. Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells. Mol Neurobiol 47, 1000–1010 (2013). https://doi.org/10.1007/s12035-013-8403-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-013-8403-0

Keywords

Navigation